Search Results - "Kwast, Annemiek"

Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval by Witteveen, Annemieke, Kwast, Annemiek B G, Sonke, Gabe S, IJzerman, Maarten J, Siesling, Sabine

“…The association between the disease-free interval (DFI) and survival after a locoregional recurrence (LRR) or second primary (SP) breast cancer remains…”
Get full text

The effect of enhanced recovery after surgery (ERAS) in renal surgery by Elferink, Susan E. M., Bretveld, Reini, Kwast, Annemiek B. G., Asselman, Marino, Essink, Judith G. J., Potters, Jan-Willem, van der Palen, Job

“…Objective To study the effect of ERAS on a textbook outcome (TO) after elective renal surgery. Patients and methods Retrospective study of all patients who…”
Get full text

A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making by Pleijhuis, Rick G, Kwast, Annemiek B.G, Jansen, Liesbeth, de Vries, Jakob, Lanting, Rosanne, Bart, Joost, Wiggers, Theo, van Dam, Gooitzen M, Siesling, Sabine

“…Abstract Background Breast-conserving therapy, consisting of lumpectomy and adjuvant radiotherapy, is considered standard treatment for early-stage breast…”
Get full text

Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span by Lebbink, Chantal A, van den Broek, Medard F. M, Kwast, Annemiek B. G, Derikx, Joep P. M, Dierselhuis, Miranda P, Kruijff, Schelto, Links, Thera P, van Trotsenburg, A. S. Paul, Valk, Gerlof D, Vriens, Menno R, Verrijn Stuart, Annemarie A, van Santen, Hanneke M, Karim-Kos, Henrike E

“…Thyroid cancer is the most common endocrine malignancy in children. A rising incidence has been reported worldwide. Possible explanations include the increased…”
Get full text

Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences by Kwast, Annemiek B. G., Groothuis-Oudshoorn, Karin C. G. M., Grandjean, Ilse, Ho, Vincent K. Y., Voogd, Adri C., Menke-Pluymers, Marian B. E., van der Sangen, Maurice J. C., Tjan-Heijnen, Vivianne C. G., Kiemeney, Lambertus A., Siesling, Sabine

“…Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and appears to have a distinct biology. Inconsistent findings…”
Get full text

Validity of the BreastConservation! nomogram evaluated by Pleijhuis, Rick G, Kwast, Annemiek B.G, Jansen, Liesbeth, de Vries, Jakob, Wiggers, Theo, Siesling, Sabine, van Dam, Gooitzen M

Get full text

Correction: Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. Cancers 2021, 13, 5104 by Lebbink, Chantal A., van den Broek, Medard F. M., Kwast, Annemiek B. G., Derikx, Joep P. M., Dierselhuis, Miranda P., Kruijff, Schelto, Links, Thera P., van Trotsenburg, A. S. Paul, Valk, Gerlof D., Vriens, Menno R., Verrijn Stuart, Annemarie A., van Santen, Hanneke M., Karim-Kos, Henrike E.

“…Error in Figure/Table [...]…”
Get full text

Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP‐3 survey by Siesling, Sabine, Kwast, Annemiek, Gavin, Anna, Baili, Paolo, Otter, Renee

“…EUROCHIP (European Cancer Health Indicators Project) focuses on understanding inequalities in the cancer burden, care and survival by the indicators “stage at…”
Get full text

ERAS embedded in VBHC context by Kwast, Annemiek, Bretveld, Reini, van Aarsen, Marjolein, van Duyn, Eino, van Ieperen, Roland

Get full text

Patient experiences with the ERAS programme by Kwast, Annemiek, Bretveld, Reini, van Aarsen, Marjolein, van Duyn, Eino, van Ieperen, Roland

Get full text

Attending the breast screening programme after breast cancer treatment: A population-based study by de Munck, Linda, Kwast, Annemiek, Reiding, Dick, de Bock, Geertruida H, Otter, Renée, Willemse, Pax H.B, Siesling, Sabine

“…Abstract Introduction In the Netherlands, breast cancer patients are treated and followed at least 5 years after diagnosis. Furthermore, all women aged 50–74…”
Get full text